Making Waves in Parkinson’s Disease: FDA-Approved Staged Bilateral Focused Ultrasound for Motor Complications

Thursday, October 23, 2025 | 6:00 PM - 7:00 PM Eastern

Join neurosurgeon Dr. Michael Kaplitt and neurologist Dr. Harini Sarva of Weill Cornell Medicine as they present the latest FDA-approved indication for staged bilateral MR-guided focused ultrasound for Parkinson’s disease targeting the pallidothalamic tract (PTT). This session will cover:

• Clinical significance of staged bilateral therapy for advanced Parkinson’s with motor complications
• Patient selection criteria and treatment considerations
• Practical insights from both surgical and neurological perspectives

This educational webinar is designed for physicians and care teams seeking to better understand how staged bilateral focused ultrasound can be integrated into the continuum of care for Parkinson’s disease patients.

Presenters

Michael Kaplitt, MD PhD.
Professor and Vice-Chair for Research in the Department of Neurological Surgery at Weill Cornell Medicine.

Harini Sarva, MD
Associate Professor of Clinical Neurology at Weill Cornell Medicine and Director of the Institute for Parkinson's Disease & Movement Disorders at Weill Cornell Medicine.